Bioton Stock: price and insider trades · Poland
PL·Mcap PLN 322.8M
No insider purchase over the last 90 days. The latest, by Ju Bo Liu, was filed 31 Jul 2026.
Bioton: what insiders have been doing
Bioton has a thin disclosure history in our data (latest filing: 31 July 2026). New filings will appear here as soon as they are published. This summary is built from KNF disclosures alone and does not predict where the share price will go.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleJu Bo Liu1 buy
Fundamental score
Ranked 14,154 of 26,913 companies
50.0
score / 100
Value57
Quality43
FCF yld3.2%
Earn yld1.1%
EV/EBITDA6.9x
ROE-1.4%
Gross mgn32%
Net mgn1.2%
Debt/EBITDA1.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
PLN 3.76
Analyst consensus
Income statement
RevenuePLN 282.5M
Gross profitPLN 91.8M32% margin
EBITDAPLN 51.4M18% margin
Net incomePLN 3.4M-3.2% margin
Valuation
PER (trailing)75.6x
P/Book0.6x
Beta0.16
Balance sheet & cash
Market capPLN 322.8M
Total debtPLN 57.2M
Free Cash FlowPLN 9.6M
Debt / Equity12%
Profitability & ownership
ROE-1.4%
ROA-0.3%
% insiders54.8%
% institutions0.3%
Last declaration on 31 July 2026
Declarations1 total
- ▲Executives0KNF
1 of 1 declaration
About Bioton
Bioton is a company listed on the XWAR market, specializing in the biopharmaceutical sector. It focuses on the development and production of innovative drugs and treatments.